Johnson Pharmacare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/02/2023 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that a meeting of the Board of Directors of the Company will be held on Thursday February 02, 2023 inter alia, to approve and take on record the Un-Audited Financial Results of the Company for the quarter ended on 31st December 2022 also transact other business activities.
Please take the above intimation in your records.
Thanking You.
|